Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Thursday's Intraday Session

Author: Benzinga Insights | March 28, 2024 12:31pm

Gainers

  • Avalo Therapeutics (NASDAQ:AVTX) stock rose 363.1% to $22.0 during Thursday's regular session. The company's market cap stands at $17.6 million.
  • Xilio Therapeutics (NASDAQ:XLO) stock rose 133.95% to $1.5. The company's market cap stands at $41.1 million.
  • Biodexa Pharmaceuticals (NASDAQ:BDRX) stock increased by 71.82% to $1.48. The market value of their outstanding shares is at $6.2 million.
  • Mesoblast (NASDAQ:MESO) stock increased by 44.41% to $5.04. The company's market cap stands at $511.4 million.
  • Ontrak (NASDAQ:OTRK) stock increased by 37.66% to $0.82. The company's market cap stands at $22.5 million.
  • Nexalin Technology (NASDAQ:NXL) stock moved upwards by 35.85% to $1.06. The company's market cap stands at $7.7 million.

Losers

  • Tonix Pharmaceuticals (NASDAQ:TNXP) shares decreased by 35.8% to $0.21 during Thursday's regular session. The market value of their outstanding shares is at $12.3 million.
  • Kodiak Sciences (NASDAQ:KOD) stock fell 18.6% to $6.07. The market value of their outstanding shares is at $318.2 million. As per the press release, Q4 earnings came out today.
  • NuCana (NASDAQ:NCNA) shares decreased by 15.19% to $0.26. The company's market cap stands at $13.7 million.
  • Oncology Institute (NASDAQ:TOI) shares fell 13.59% to $1.59. The company's market cap stands at $117.2 million. As per the news, the Q4 earnings report came out yesterday.
  • Vincerx Pharma (NASDAQ:VINC) stock fell 13.21% to $5.26. The market value of their outstanding shares is at $112.4 million.
  • ENDRA Life Sciences (NASDAQ:NDRA) stock decreased by 13.13% to $0.71. The market value of their outstanding shares is at $7.8 million. As per the press release, Q4 earnings came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AVTX BDRX KOD MESO NCNA NDRA NXL OTRK TNXP TOI VINC XLO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist